Qube Research & Technologies (QRT)
VIR icon

Qube Research & Technologies (QRT)’s Vir Biotechnology VIR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Sell
641,486
-607,183
-49% -$5.78M 0.01% 1499
2026
Q1 		$11.2M Buy
1,248,669
+1,165,610
+1,403% +$9.29M 0.01% 1209
2025
Q4 		$501K Sell
83,059
-189,111
-69% -$1.13M ﹤0.01% 2803
2025
Q3 		$1.55M Sell
272,170
-167,835
-38% -$858K ﹤0.01% 2344
2025
Q2 		$2.22M Buy
440,005
+149,329
+51% +$801K ﹤0.01% 2163
2025
Q1 		$1.88M Buy
290,676
+135,767
+88% +$1.21M ﹤0.01% 1976
2024
Q4 		$1.14M Sell
154,909
-203,177
-57% -$1.6M ﹤0.01% 2121
2024
Q3 		$2.68M Buy
358,086
+332,421
+1,295% +$2.89M ﹤0.01% 1652
2024
Q2 		$228K Sell
25,665
-161,178
-86% -$1.55M ﹤0.01% 2392
2024
Q1 		$1.89M Sell
186,843
-31,546
-14% -$321K ﹤0.01% 1793
2023
Q4 		$2.2M Buy
218,389
+178,141
+443% +$1.63M ﹤0.01% 1485
2023
Q3 		$377K Buy
40,248
+5,787
+17% +$82.5K ﹤0.01% 2148
2023
Q2 		$845K Buy
+34,461
New +$865K ﹤0.01% 1365
2022
Q2 		– Sell
-328,914
Closed -$8.46M – 3172
2022
Q1 		$8.46M Buy
+328,914
New +$9.76M 0.07% 362
2020
Q2 		– Sell
-25,867
Closed -$886K – 2013
2020
Q1 		$886K Buy
+25,867
New +$695K 0.04% 421

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VIR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Vir Biotechnology (VIR) stake by 49% in Q2 2026, selling an estimated $5.78M and leaving 641,486 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #1499.

Qube Research & Technologies (QRT) first reported a position in VIR in Q1 2020 and has held it in 15 quarters since. The position peaked at $11.2M in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 641,486 shares of Vir Biotechnology worth $6.54M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 607,183 Vir Biotechnology shares in Q2 2026, an estimated $5.78M.
  • Vir Biotechnology made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1499 holding.
  • Qube Research & Technologies (QRT) first reported a position in Vir Biotechnology in Q1 2020 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s Vir Biotechnology position peaked at $11.2M in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.